{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:16:27Z","timestamp":1767910587636,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00415-023-11702-5","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T21:01:30Z","timestamp":1682629290000},"page":"3876-3884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study"],"prefix":"10.1007","volume":"270","author":[{"given":"Yuting","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-4188","authenticated-orcid":false,"given":"Xunsha","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"issue":"2","key":"11702_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.22427","volume":"70","author":"S Bigi","year":"2011","unstructured":"Bigi S, Fischer U, Wehrli E et al (2011) Acute ischemic stroke in children versus young adults. Ann Neurol 70(2):245\u2013254. https:\/\/doi.org\/10.1002\/ana.22427","journal-title":"Ann Neurol"},{"key":"11702_CR2","doi-asserted-by":"publisher","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52(5):245\u2013266. https:\/\/doi.org\/10.2176\/nmc.52.245","DOI":"10.2176\/nmc.52.245"},{"issue":"1","key":"11702_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS (2016) Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke 18(1):2\u201311. https:\/\/doi.org\/10.5853\/jos.2015.01627","journal-title":"J Stroke"},{"issue":"5","key":"11702_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/strokeaha.118.022490","volume":"50","author":"C Jeon","year":"2019","unstructured":"Jeon C, Yeon JY, Jo KI et al (2019) Clinical role of microembolic signals in adult moyamoya disease with ischemic stroke. Stroke 50(5):1130\u20131135. https:\/\/doi.org\/10.1161\/strokeaha.118.022490","journal-title":"Stroke"},{"issue":"1","key":"11702_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/strokeaha.116.014529","volume":"48","author":"DY Kim","year":"2017","unstructured":"Kim DY, Son JP, Yeon JY et al (2017) Infarct pattern and collateral status in adult moyamoya disease: a multimodal magnetic resonance imaging study. Stroke 48(1):111\u2013116. https:\/\/doi.org\/10.1161\/strokeaha.116.014529","journal-title":"Stroke"},{"issue":"12","key":"11702_CR6","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1007\/s00415-022-11323-4","volume":"269","author":"M Pompsch","year":"2022","unstructured":"Pompsch M, Veltkamp R, Diehl RR et al (2022) Microembolic signals and antiplatelet therapy in moyamoya angiopathy. J Neurol 269(12):6605\u20136612. https:\/\/doi.org\/10.1007\/s00415-022-11323-4","journal-title":"J Neurol"},{"issue":"1","key":"11702_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.str.14.1.104","volume":"14","author":"J Suzuki","year":"1983","unstructured":"Suzuki J, Kodama N (1983) Moyamoya disease\u2014a review. Stroke 14(1):104\u2013109. https:\/\/doi.org\/10.1161\/01.str.14.1.104","journal-title":"Stroke"},{"issue":"7","key":"11702_CR8","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1161\/strokeaha.112.654004","volume":"43","author":"HW Nah","year":"2012","unstructured":"Nah HW, Kwon SU, Kang DW et al (2012) Moyamoya disease-related versus primary intracerebral hemorrhage: [corrected] location and outcomes are different. Stroke 43(7):1947\u20131950. https:\/\/doi.org\/10.1161\/strokeaha.112.654004","journal-title":"Stroke"},{"key":"11702_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3389\/fneur.2020.00517","volume":"11","author":"J Lu","year":"2020","unstructured":"Lu J, Li Z, Zhao Y et al (2020) Hemorrhagic transformation in ischemic moyamoya disease: clinical characteristics, radiological features, and outcomes. Front Neurol 11:517. https:\/\/doi.org\/10.3389\/fneur.2020.00517","journal-title":"Front Neurol"},{"issue":"7","key":"11702_CR10","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/strokeaha.122.036884","volume":"53","author":"L Li","year":"2022","unstructured":"Li L, Murthy SB (2022) Cardiovascular events after intracerebral hemorrhage. Stroke 53(7):2131\u20132141. https:\/\/doi.org\/10.1161\/strokeaha.122.036884","journal-title":"Stroke"},{"issue":"6","key":"11702_CR11","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00381-021-05074-2","volume":"37","author":"HL Srinivasan","year":"2021","unstructured":"Srinivasan HL, Hausman-Kedem M, Smith ER et al (2021) Current trends in pediatric moyamoya: a survey of international practitioners. Childs Nerv Syst 37(6):2011\u20132023. https:\/\/doi.org\/10.1007\/s00381-021-05074-2","journal-title":"Childs Nerv Syst"},{"issue":"12","key":"11702_CR12","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/s1474-4422(09)70241-8","volume":"8","author":"NA Goldenberg","year":"2009","unstructured":"Goldenberg NA, Bernard TJ, Fullerton HJ et al (2009) Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol 8(12):1120\u20131127. https:\/\/doi.org\/10.1016\/s1474-4422(09)70241-8","journal-title":"Lancet Neurol"},{"issue":"5","key":"11702_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3171\/2009.4.JNS081649","volume":"111","author":"R Guzman","year":"2009","unstructured":"Guzman R, Lee M, Achrol A et al (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease: clinical article. J Neurosurg 111(5):927\u2013935. https:\/\/doi.org\/10.3171\/2009.4.JNS081649","journal-title":"J Neurosurg"},{"issue":"8","key":"11702_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/s1474-4422(22)00165-x","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y et al (2022) Moyamoya disease: diagnosis and interventions. Lancet Neurol 21(8):747\u2013758. https:\/\/doi.org\/10.1016\/s1474-4422(22)00165-x","journal-title":"Lancet Neurol"},{"issue":"3\u20136","key":"11702_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000504835","volume":"48","author":"M Kameyama","year":"2020","unstructured":"Kameyama M, Fujimura M, Tashiro R et al (2020) Significance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya disease: implication for the pathological threshold of local cerebral hyperperfusion. Cerebrovasc Dis 48(3\u20136):217\u2013225. https:\/\/doi.org\/10.1159\/000504835","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"11702_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3340\/jkns.2011.50.6.492","volume":"50","author":"YJ Jung","year":"2011","unstructured":"Jung YJ, Ahn JS, Kwon DH et al (2011) Ischemic complications occurring in the contralateral hemisphere after surgical treatment of adults with moyamoya disease. J Korean Neurosurg Soc 50(6):492\u2013496. https:\/\/doi.org\/10.3340\/jkns.2011.50.6.492","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"11702_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","volume":"43","author":"S Shang","year":"2020","unstructured":"Shang S, Zhou D, Ya J et al (2020) Progress in moyamoya disease. Neurosurg Rev 43(2):371\u2013382. https:\/\/doi.org\/10.1007\/s10143-018-0994-5","journal-title":"Neurosurg Rev"},{"issue":"5","key":"11702_CR18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/strokeaha.115.012168","volume":"47","author":"WL Titsworth","year":"2016","unstructured":"Titsworth WL, Scott RM, Smith ER (2016) National analysis of 2454 pediatric moyamoya admissions and the effect of hospital volume on outcomes. Stroke 47(5):1303\u20131311. https:\/\/doi.org\/10.1161\/strokeaha.115.012168","journal-title":"Stroke"},{"key":"11702_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.608000","author":"F Ye","year":"2021","unstructured":"Ye F, Li J, Wang T et al (2021) Efficacy and safety of antiplatelet agents for adult patients with ischemic moyamoya disease. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.608000","journal-title":"Front Neurol"},{"key":"11702_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.017701","author":"W-K Seo","year":"2021","unstructured":"Seo W-K, Kim J-Y, Choi E-H et al (2021) Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.120.017701","journal-title":"J Am Heart Assoc"},{"key":"11702_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009942","author":"D Onozuka","year":"2016","unstructured":"Onozuka D, Hagihara A, Nishimura K et al (2016) Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study). BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2015-009942","journal-title":"BMJ Open"},{"issue":"5","key":"11702_CR22","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00701-020-04668-0","volume":"163","author":"F Kanamori","year":"2021","unstructured":"Kanamori F, Araki Y, Yokoyama K et al (2021) Effects of aspirin and heparin treatment on perioperative outcomes in patients with moyamoya disease. Acta Neurochir 163(5):1485\u20131491. https:\/\/doi.org\/10.1007\/s00701-020-04668-0","journal-title":"Acta Neurochir"},{"issue":"4","key":"11702_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10143-016-0734-7","volume":"39","author":"S Rashad","year":"2016","unstructured":"Rashad S, Fujimura M, Niizuma K et al (2016) Long-term follow-up of pediatric moyamoya disease treated by combined direct\u2013indirect revascularization surgery: single institute experience with surgical and perioperative management. Neurosurg Rev 39(4):615\u2013623. https:\/\/doi.org\/10.1007\/s10143-016-0734-7","journal-title":"Neurosurg Rev"},{"key":"11702_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.wneu.2017.06.057","volume":"105","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Zhang Q, Zhang D et al (2017) Effect of aspirin in postoperative management of adult ischemic moyamoya disease. World Neurosurg 105:728\u2013731. https:\/\/doi.org\/10.1016\/j.wneu.2017.06.057","journal-title":"World Neurosurg"},{"issue":"12","key":"11702_CR25","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.030","volume":"27","author":"K Oki","year":"2018","unstructured":"Oki K, Katsumata M, Izawa Y et al (2018) Trends of antiplatelet therapy for the management of moyamoya disease in Japan: results of a nationwide survey. J Stroke Cerebrovasc Dis 27(12):3605\u20133612. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.08.030","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"11702_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99009-1","author":"CH Pang","year":"2021","unstructured":"Pang CH, Cho W-S, Kang H-S et al (2021) Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease. Sci Reports. https:\/\/doi.org\/10.1038\/s41598-021-99009-1","journal-title":"Sci Reports"},{"issue":"2","key":"11702_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000518725","volume":"51","author":"K Kitakami","year":"2022","unstructured":"Kitakami K, Kubo Y, Yabuki M et al (2022) Five-year outcomes of medical management alone for adult patients with ischemic moyamoya disease without cerebral misery perfusion. Cerebrovasc Dis 51(2):158\u2013164. https:\/\/doi.org\/10.1159\/000518725","journal-title":"Cerebrovasc Dis"},{"key":"11702_CR28","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"12","key":"11702_CR29","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12(12):1495\u20131499. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013","journal-title":"Int J Surg"},{"issue":"5","key":"11702_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis): Esearch Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis","year":"2012","unstructured":"Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis): Esearch Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis (2012) Health labour sciences research grant for research on measures for intractable diseases. Neurol Med Chir 52(5):245\u2013266. https:\/\/doi.org\/10.2176\/nmc.52.245","journal-title":"Neurol Med Chir"},{"issue":"2","key":"11702_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","volume":"9","author":"L Li","year":"2013","unstructured":"Li L, Greene T (2013) A weighting analogue to pair matching in propensity score analysis. Int J Biostat 9(2):215\u2013234. https:\/\/doi.org\/10.1515\/ijb-2012-0030","journal-title":"Int J Biostat"},{"issue":"4","key":"11702_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S et al (2022) 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and Japan Stroke Society. Neurol Med Chir (Tokyo) 62(4):165\u2013170. https:\/\/doi.org\/10.2176\/jns-nmc.2021-0382","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"10191","key":"11702_CR33","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1016\/s0140-6736(19)30840-2","volume":"393","author":"R Al-Shahi Salman","year":"2019","unstructured":"Al-Shahi Salman R et al (2019) Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet 393(10191):2613\u20132623. https:\/\/doi.org\/10.1016\/s0140-6736(19)30840-2","journal-title":"Lancet"},{"issue":"1","key":"11702_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1468-1331.2011.03481.x","volume":"19","author":"M Kraemer","year":"2012","unstructured":"Kraemer M, Berlit P, Diesner F et al (2012) What is the expert\u2019s option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey. Eur J Neurol 19(1):163\u2013167. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03481.x","journal-title":"Eur J Neurol"},{"issue":"4","key":"11702_CR35","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/strokeaha.113.004273","volume":"45","author":"IM Ahn","year":"2014","unstructured":"Ahn IM, Park DH, Hann HJ et al (2014) Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke 45(4):1090\u20131095. https:\/\/doi.org\/10.1161\/strokeaha.113.004273","journal-title":"Stroke"},{"key":"11702_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/23969873221144089","author":"AKN Bersano","year":"2023","unstructured":"Bersano AKN, Fuentes B et al (2023) European Stroke Organisation (ESO) guidelines on moyamoya angiopathy: endorsed by vascular European reference network (VASCERN). Eur Stroke J. https:\/\/doi.org\/10.1177\/23969873221144089","journal-title":"Eur Stroke J"},{"issue":"17","key":"11702_CR37","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.Cir.0000163561.90680.1c","volume":"111","author":"HS Markus","year":"2005","unstructured":"Markus HS, Droste DW, Kaps M et al (2005) Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 111(17):2233\u20132240. https:\/\/doi.org\/10.1161\/01.Cir.0000163561.90680.1c","journal-title":"Circulation"},{"issue":"16","key":"11702_CR38","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","volume":"374","author":"P Amarenco","year":"2016","unstructured":"Amarenco P, Lavall\u00e9e PC, Labreuche J et al (2016) One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 374(16):1533\u20131542. https:\/\/doi.org\/10.1056\/NEJMoa1412981","journal-title":"N Engl J Med"},{"key":"11702_CR39","doi-asserted-by":"publisher","first-page":"8255018","DOI":"10.1155\/2022\/8255018","volume":"2022","author":"SC Yu","year":"2022","unstructured":"Yu SC, Yin ZH, Zeng CF et al (2022) Infarction patterns and recurrent adverse cerebrovascular events in moyamoya disease. Dis Markers 2022:8255018. https:\/\/doi.org\/10.1155\/2022\/8255018","journal-title":"Dis Markers"},{"issue":"6","key":"11702_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/jamaneurol.2018.0247","volume":"75","author":"J Jing","year":"2018","unstructured":"Jing J, Meng X, Zhao X et al (2018) Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial. JAMA Neurol 75(6):711\u2013719. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0247","journal-title":"JAMA Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11702-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11702-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11702-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T13:05:47Z","timestamp":1689253547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11702-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["11702"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11702-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This is an observational study. The Clinical Research and Laboratory Animal Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}